" /> Autologous Anti-CD19 CAR-T Cells GC019F - CISMeF





Preferred Label : Autologous Anti-CD19 CAR-T Cells GC019F;

NCIt synonyms : Autologous CD19-targeted CAR T Cells GC019F; Autologous FasTCAR-enabled CD19-targeted CAR T-cells GC019F;

NCIt definition : A preparation of autologous T-lymphocytes that have been genetically modified to express a chimeric antigen receptor (CAR) specific for the tumor-associated antigen (TAA) CD19, with potential immunostimulating and antineoplastic activities. Upon administration, autologous anti-CD19 CAR-T cells GC019F target and bind to CD19-expressing tumor cells. This results in a cytotoxic T-lymphocyte (CTL) response against CD19-expressing tumor cells, the release of cytotoxic molecules and the induction of tumor cell lysis. CD19, cluster of differentiation 19, is a B-cell-specific cell surface antigen overexpressed in B-cell lineage tumors. The processing platform used, FasTCAR, shortens the manufacturing time to produce the CAR-T cells.;

Molecule name : GC 019F; GC-019F;

NCI Metathesaurus CUI : CL1648074;

Détails


Vous pouvez consulter :


Nous contacter.
29/07/2025


[Accueil] [Haut de page]

© CHU de Rouen. Toute utilisation partielle ou totale de ce document doit mentionner la source.